Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis

First Foundation Labs partners with Microsoft to bring AI-powered clinical and translational reasoning to Microsoft Discovery

FDA accepts Genentech's giredestrant application for early-stage breast cancer

Ansun Biopharma reports positive recommendation from independent DMC for DAS181

Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC

Haisco receives US FDA approval for anaesthetic Cipepofol

hVIVO secures Decoy Therapeutics consultancy contract for antiviral development

AstraZeneca reports trial results showing immunotherapy combinations reduce progression risk in liver cancer

Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing

IBA launches Cyclone iKure for industrial-scale Astatine-211 production

Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy

Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026

TiumBio presents Phase 2a interim data for Tosposertib plus pembrolizumab at ASCO 2026

ImmVira reports 100% CRR at 9 months in bladder carcinoma in situ with MVR-T3011